1. Home
  2. BGC vs ALKS Comparison

BGC vs ALKS Comparison

Compare BGC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGC
  • ALKS
  • Stock Information
  • Founded
  • BGC 1945
  • ALKS 1987
  • Country
  • BGC United States
  • ALKS Ireland
  • Employees
  • BGC N/A
  • ALKS N/A
  • Industry
  • BGC Investment Bankers/Brokers/Service
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGC Finance
  • ALKS Health Care
  • Exchange
  • BGC Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • BGC 4.3B
  • ALKS 5.1B
  • IPO Year
  • BGC 1999
  • ALKS 1991
  • Fundamental
  • Price
  • BGC $10.85
  • ALKS $28.75
  • Analyst Decision
  • BGC Strong Buy
  • ALKS Buy
  • Analyst Count
  • BGC 2
  • ALKS 12
  • Target Price
  • BGC $14.50
  • ALKS $40.00
  • AVG Volume (30 Days)
  • BGC 3.4M
  • ALKS 1.8M
  • Earning Date
  • BGC 07-31-2025
  • ALKS 07-23-2025
  • Dividend Yield
  • BGC 0.74%
  • ALKS N/A
  • EPS Growth
  • BGC 128.63
  • ALKS N/A
  • EPS
  • BGC 0.27
  • ALKS 2.09
  • Revenue
  • BGC $2,252,851,000.00
  • ALKS $1,513,770,000.00
  • Revenue This Year
  • BGC $35.79
  • ALKS N/A
  • Revenue Next Year
  • BGC $9.83
  • ALKS $4.25
  • P/E Ratio
  • BGC $40.88
  • ALKS $13.69
  • Revenue Growth
  • BGC 13.24
  • ALKS N/A
  • 52 Week Low
  • BGC $7.24
  • ALKS $22.90
  • 52 Week High
  • BGC $11.79
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • BGC 75.90
  • ALKS 38.57
  • Support Level
  • BGC $9.13
  • ALKS $28.49
  • Resistance Level
  • BGC $9.85
  • ALKS $30.00
  • Average True Range (ATR)
  • BGC 0.28
  • ALKS 0.75
  • MACD
  • BGC 0.12
  • ALKS -0.09
  • Stochastic Oscillator
  • BGC 98.56
  • ALKS 10.80

About BGC BGC Group Inc.

BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: